A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

NCT05985161 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Wilms Tumor
Rhabdoid Tumor
Malignant Peripheral Nerve Sheath Tumors
MPNST
Nephroblastoma
XPO1 Gene Mutation
Solid Tumor

Interventions

DRUG: Selinexor

Sponsor

Memorial Sloan Kettering Cancer Center